Log in
Enquire now
‌

US Patent 11535679 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma

Patent 11535679 was granted and assigned to Genmab A/S on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Genmab A/S
0
Current Assignee
‌
Genmab A/S
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115356790
Patent Inventor Names
Brian Elliott0
Tahamtan Ahmadi0
Esther C. W. Breij0
Christopher W. L. Chiu0
Date of Patent
December 27, 2022
0
Patent Application Number
175584040
Date Filed
December 21, 2021
0
Patent Citations
‌
US Patent 10590206 Inert format
‌
US Patent 10906991 Bispecific antibodies and methods for production thereof
0
‌
US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof
0
‌
US Patent 10273227 C5-anilinoquinazoline compounds and their use in treating cancer
‌
US Patent 10344050 Production of heterodimeric proteins
0
‌
US Patent 10407501 Humanized or chimeric CD3 antibodies
0
‌
US Patent 10465006 Humanized or chimeric CD3 antibodies
‌
US Patent 10544220 Bispecific antibodies against CD3 and CD20
Patent Citations Received
‌
US Patent 11858995 Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia
0
Patent Primary Examiner
‌
Karen A. Canella
0
CPC Code
‌
C07K 16/2887
0
‌
A61K 2039/505
0
‌
A61K 45/06
0
‌
A61K 2300/00
0
‌
C07K 2317/31
0
‌
A61K 2039/545
0
‌
C07K 16/2809
0

Provided are methods of clinical treatment of follicular lymphoma (for example, relapsed and/or refractory follicular lymphoma) in human subjects using a bispecific antibody which binds to CD3 and CD20 in combination with standard of care regimens of rituximab and bendamustine.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11535679 Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.